Mirae Asset Global Etfs Holdings Ltd. Ultragenyx Pharmaceutical Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $47.1 Billion
- Q2 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 60,255 shares of RARE stock, worth $1.88 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,255
Previous 61,778
2.47%
Holding current value
$1.88 Million
Previous $2.24 Million
2.06%
% of portfolio
0.0%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding RARE
# of Institutions
364Shares Held
89.1MCall Options Held
3.64MPut Options Held
2.24M-
Vanguard Group Inc Valley Forge, PA10.2MShares$319 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$175 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA3.94MShares$123 Million0.43% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.89MShares$90.1 Million0.01% of portfolio
-
Baker Bros. Advisors LP New York, NY2.77MShares$86.5 Million1.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.19B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...